We’re hosting a webinar on DOJ’s new cross-border sensitive bulk data rules that apply to most companies that handle genomic or personal health data, or conduct clinical trials. The regime is bipartisan and here to stay. @miriamwugmeister.bsky.social
Register at www.veracast.com/webcasts/mof...
Today on “The Regulators,” @sranderson.bsky.social and I talk to the DOJ official who oversees enforcement of the Foreign Agents Registration Act (FARA) on the newly proposed FARA regulations. We give a tutorial on FARA and dive deep into the impact of the proposed regulations.
Amid the flood of regulations recently issued by the Biden administration, new restrictions on transactions involving or access to sensitive data may be the most far reaching. Most global firms w/ sensitive data will be impacted. Goes live in April.
Details below.
www.mofo.com/resources/in...
For anyone interested in a deep dive of DOJ's proposed changes to the Foreign Agents Registration Act (FARA), here's a comprehensive summary. As proposed, global firms and non-profits would need to reassess their FARA risk and exposure. Comments due March 3.
www.mofo.com/resources/in...
DOJ just proposed the most significant changes to the Foreign Agents Registration Act (FARA) in 30 years. Lots to unpack. Main change would significantly narrow the commercial exemptions; many global firms would need to reassess their FARA exposure.
www.justice.gov/opa/pr/justi...
Look forward to reengaging with you all. Lots to unpack going forward.
